Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020): The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy

  • Tim R. Eijgenraam
  • , Bastiaan J. Boukens
  • , Cornelis J. Boogerd
  • , E. Marloes Schouten
  • , Cees W.A. van de Kolk
  • , Nienke M. Stege
  • , Wouter P. te Rijdt
  • , Edgar T. Hoorntje
  • , Paul A. van der Zwaag
  • , Eva van Rooij
  • , J. Peter van Tintelen
  • , Maarten P. van den Berg
  • , Peter van der Meer
  • , Jolanda van der Velden
  • , Herman H.W. Silljé
  • , Rudolf A. de Boer*
  • *Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

5 Downloads (Pure)

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Original languageEnglish
Article number16710
JournalScientific Reports
Volume10
Issue number1
DOIs
Publication statusPublished - 2 Oct 2020

Fingerprint

Dive into the research topics of 'Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020): The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy'. Together they form a unique fingerprint.

Cite this